These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23329352)
1. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes. Mesquita B; Lopes P; Rodrigues A; Pereira D; Afonso M; Leal C; Henrique R; Lind GE; Jerónimo C; Lothe RA; Teixeira MR Breast Cancer Res Treat; 2013 Feb; 138(1):37-45. PubMed ID: 23329352 [TBL] [Abstract][Full Text] [Related]
2. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR; Seth A; Rosenberg M; Papas T; Debouck C; Kola I Oncogene; 1997 Nov; 15(20):2449-62. PubMed ID: 9395241 [TBL] [Abstract][Full Text] [Related]
3. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154 [TBL] [Abstract][Full Text] [Related]
4. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471 [TBL] [Abstract][Full Text] [Related]
5. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936 [TBL] [Abstract][Full Text] [Related]
6. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression. Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337 [TBL] [Abstract][Full Text] [Related]
7. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium. Jobling AI; Fang Z; Koleski D; Tymms MJ Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165 [TBL] [Abstract][Full Text] [Related]
8. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression. Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182 [TBL] [Abstract][Full Text] [Related]
9. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Zhou J; Ng AY; Tymms MJ; Jermiin LS; Seth AK; Thomas RS; Kola I Oncogene; 1998 Nov; 17(21):2719-32. PubMed ID: 9840936 [TBL] [Abstract][Full Text] [Related]
10. Locations of the ets subfamily members net, elk1, and sap1 (ELK3, ELK1, and ELK4) on three homologous regions of the mouse and human genomes. Giovane A; Sobieszczuk P; Mignon C; Mattei MG; Wasylyk B Genomics; 1995 Oct; 29(3):769-72. PubMed ID: 8575773 [TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Courjal F; Theillet C Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100 [TBL] [Abstract][Full Text] [Related]
12. Partially unspliced and fully spliced ELF3 mRNA, including a new Alu element in human breast cancer. Kaplan MH; Wang XP; Xu HP; Dosik MH Breast Cancer Res Treat; 2004 Jan; 83(2):171-87. PubMed ID: 14997048 [TBL] [Abstract][Full Text] [Related]
13. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205 [TBL] [Abstract][Full Text] [Related]
14. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression. Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734 [TBL] [Abstract][Full Text] [Related]
15. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Oettgen P; Barcinski M; Boltax J; Stolt P; Akbarali Y; Libermann TA Genomics; 1999 Feb; 55(3):358-62. PubMed ID: 10049594 [TBL] [Abstract][Full Text] [Related]
16. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Span PN; Manders P; Heuvel JJ; Thomas CM; Bosch RR; Beex LV; Sweep CG Oncogene; 2002 Dec; 21(55):8506-9. PubMed ID: 12466970 [TBL] [Abstract][Full Text] [Related]
17. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer. Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150 [TBL] [Abstract][Full Text] [Related]
18. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells. Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025 [TBL] [Abstract][Full Text] [Related]
19. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478 [TBL] [Abstract][Full Text] [Related]
20. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]